Regulatory standardisation to improve the safety of continuous glucose monitoring systems in Australia and New Zealand: joint ADS / ADEA / ADIPS / ANZSPED / NZSSD statement

Internal Medicine Journal · Published 2026-07-29 · DOI 10.1111/imj.70586

Free full text

Authors (15)

Sofianos Andrikopoulos, Lisa M. Raven, Ramzi Ajjan, Kate Lomax, Tara Whelan, Brett Fenton, Amanda Bartlett, Shantha Joseph, Matthew Hare, Mary B. Abraham, Hamish R. Crocket, Tom M. Wilkinson, Joanna McClintock, Benjamin J. Wheeler, Glynis P. Ross

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Andrikopoulos, S., Raven, L., Ajjan, R., et al. (2026). Regulatory standardisation to improve the safety of continuous glucose monitoring systems in Australia and New Zealand: joint ADS / ADEA / ADIPS / ANZSPED / NZSSD statement. Internal Medicine Journal. https://doi.org/10.1111/imj.70586

Related articles

• Race‐neutral lung function equations and clinical interpretation in East Asian patients · Internal Medicine Journal · 2026 · Same journal
• Methodological considerations in the pre‐implementation evaluation of AI ‐guided surgical antimicrobial prophylaxis · Internal Medicine Journal · 2026 · Same journal
• Vitamin B6: too much, too little, too late? An analysis of sales trends in Australia from 2023 to 2025 · Internal Medicine Journal · 2026 · Same journal
• Assessing lung health disparities in Aboriginal Australians: inter‐community variation in spirometry pattern among adult Aboriginal people in rural and remote Australia · Internal Medicine Journal · 2026 · Same journal
• Improving primary aldosteronism diagnosis and treatment: outcomes from an endocrine hypertension service · Internal Medicine Journal · 2026 · Same journal
• Trustworthy artificial intelligence for rural health care · Internal Medicine Journal · 2026 · Same journal
• Unravelling the paradox of smoking cessation in multimorbidity: the roles of polypharmacy and treatment burden · Internal Medicine Journal · 2026 · Same journal
• Comparison of pharmacogenomic guidance in Australian prescribing resources and international pharmacogenomic guidelines · Internal Medicine Journal · 2026 · Same journal
• Complexity and comorbidities: critical considerations for methicillin‐resistant Staphylococcus aureus bacteraemia outcomes in the Northern Territory · Internal Medicine Journal · 2026 · Same journal
• Online tool for refining socio‐economic analyses better than postcodes: the example of cardiovascular disease in type 2 diabetes in the FIELD trial · Internal Medicine Journal · 2026 · Same journal